View allAll Photos Tagged Gastroenterologists

Robynne Chutkan

CEO, Gutbliss LLC; Integrative Gastroenterologist

 

Mark Hyman

Head of Strategy and Innovation, Cleveland Clinic Center for Functional Medicine

 

We have cancer in my family. Most people do… On my grandma’s side, pancreatic, and my grandfather’s side, colon cancer. My great-grandmother (his mother) passed away in 1989 when I was 6. We had no technology at all. Somehow, doctors could determine what it was, and she died in agony soon after. My grandfather went for a colonoscopy annually. Supposedly, everything was okay. Then, one time, his doctor in Brooklyn could not take out a polyp, and she said that if he wanted to, he could go for a second opinion, maybe to take it out. We went to the city. The gastroenterologist looked at his age and the fact that he had a colonoscopy recently and said, “No.”. According to him, he could not risk performing an invasive procedure with anesthesia at his age, especially since he got it recently. I inherited my grandma’s love for books & pens and her ability to be aggressive and annoying. My mom and aunt always say I’m just as irritating and assertive as she was. I told the MD that he had to perform another colonoscopy to make sure he was okay because, with his family history, I couldn’t take a risk. He informed me that I would need to sign a document and that I would be held accountable if something were to happen to him. Just to let people know what I can do when it comes to my family, paramedics called the police on me once, and Brooklyn Hospital brought MD from NJ to Brooklyn. When it comes to my loved ones, I’ll bite your head off. We agreed. I remember waiting for him during the procedure. The MD came out…. Did you take outa polyp? I asked. He turned pale as he looked at me. “It’s cancer.” It was early stage, operable. Then every 6 months (August and March) we went for a scan, then I took him out to eat.

 

My mom always tells me to be thankful for my life and for the opportunities in America. My response tends to frustrate her. I'm a simple person; I can be happy living on a farm surrounded by trees and water. If I have more luxuries in life, I appreciate them, but I can live with or without them. However, I will always be grateful that America has increased the life span of the people I love most in the world!

 

P.S. He yelled at me again, calling me annoying and unbearable. Occasionally, he tells me that I’m too overprotective and that I’m “too much.” Yet, he also says I’m his best gift in life. This has been our relationship for 40 years. He yells at me for being overwhelming, and I just accept it. That's what we women do—it doesn't even matter as long as we can turn things around for the better!

 

The health tests may not always be pleasant, but they are essential for everyone.

Es el estómago el turno. Qué sigue? (It's the stomach's turn. What next?)

Blog: sharonfrost.typepad.com/day_books

6 1/2 x 8 in double page spread; watercolor, ink, whatever, on Field Notes.

#waitingrooms #brooklyn #sharonfrost #urbansketchers #journals

Hepatitis, inflammation of the liver, can present many health challenges, and obtaining a diagnosis and starting treatment, when indicated, is of critical importance. The disease is most often caused by one of a number of viruses, such as hepatitis A, hepatitis B, and hepatitis C.

However, it can also be caused by other conditions, such as chronic alcohol abuse. Dr. Prasad Bhate one of the best hepatologist in Pune and also he is specialist in gastrology.

 

Additional Symptoms

addition to jaundice, patients with hepatitis may experience other symptoms that can be vaguer. These include:

 

• Loss of appetite

• Fatigue

• Low-grade fever

• Muscle or joint aches

• Nausea and vomiting

• Belly pain

 

If you are facing the problem regarding the gastroenterology, Hepatology and liver then simply call us or book an appointment with the best gastroenterolgist in Pune.

 

Book an Appointment - www.gastropune.com/book-an-appointment/

 

Call us on - +91-99233 39241

 

#gastroenterologist #liverspecialist #hepatits #hepatologist #pune #health #doctor #gastro #gastrichealth #gastroloy #liver #livertransplant

Casualty

------------

(On Ground Floor) working 24 hours to receive emergency patients, attended by experienced doctors with all emergency medical gadgets. 5 A/c consulting rooms for OPD consultation & casualty.

 

Visitor Lounge

--------------------

(Ground Floor) With TV, toilet & adequate relaxing space for patients near & dear ones, tea & coffee counter, drinking water (warm & cold), help desk, reception counter & cash counter

 

About KKasturi Hospital

---------------------------------

KKASTURI MEDICARE PVT. LTD. located at Mira Bhayandar has 60 bedded indoor facility with Polyclinic, Diagnostic Centre, ICCU, NICU, Dialysis Unit, Pediatric, Surgical, Maternity & General Hospital that meets the standards of “One Stop Hi - Tech Centre.

 

” We believe in Health Care.... Human Care"

 

For more detail about KKasturi Hospital in Mira Bhayander Visit www.kasturihospital.com

 

news.yahoo.com/how-strong-is-your-immunity-against-omicro...

 

How strong is your immunity against Omicron?

 

For months, scientists, public health officials, politicians and the general public have debated whether prior SARS-CoV-2 infection — touted as “natural immunity” — offers protection against COVID-19 that is comparable to vaccines.

 

The answer to that debate is complicated, but studies show the best way to protect yourself against the Omicron variant of the coronavirus is to get vaccinated and then boosted. An infection on top of that, while not desirable, offers even more protection.

 

Recent evidence suggests that “natural” COVID-19 protection depends on many factors, including when the infection happened, the variant involved, whether someone has been boosted or not, and the overall strength of their immune system.

 

“The question about natural versus vaccination immunity is an important one,” Monica Gandhi, an infectious disease specialist and professor of medicine at the University of California, San Francisco, told Yahoo News. “The CDC showed that up to the Delta surge, no doubt, natural immunity is likely as protective or more protective even than your two-dose vaccines,” she added.

 

Gandhi was referring to a study published two weeks ago in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report. It is the same study that GOP lawmakers pointed to this week when introducing the “Natural Immunity Transparency Act,” arguing that the CDC data “demonstrated natural immunity was 3-4 times as effective in preventing COVID-19 compared with vaccination.”

 

But this claim needs more context. The CDC study analyzed COVID-19 cases in California and New York in 2021, which together only account for about 18 percent of the U.S. population. The data was collected from May 30 to Nov. 20, 2021, a period before and during the Delta wave. The study showed that prior to Delta, which became predominant in late June and July 2021, case rates were lowest for people who were vaccinated and not previously infected with COVID-19. But by early October, when Delta was dominant, the picture changed. Case rates then were substantially lower among both unvaccinated and vaccinated people with previous infections, suggesting that natural immunity during this period was superior to vaccines.

 

However, it is important to note that the CDC research was conducted during a time when vaccine-induced immunity was waning for many people and before the emergence of the highly transmissible Omicron variant. Additionally, most U.S. adults were not yet eligible to receive booster shots, which are seen as offering the best protection against Omicron.

 

In general, studies conducted pre-Omicron do support the concept that infection-induced immunity and vaccine-induced immunity are pretty similar in terms of protection. However, Gandhi said there are many reasons vaccines are preferred. Notably, vaccines are free, safe and quick, while getting COVID-19 carries substantial risks, including long COVID, hospitalization and death. “It’s just safer,” Gandhi said.

 

She also said natural immunity can vary substantially from person to person, depending on many factors like age, the overall strength of the person’s immune system, how severe the COVID case was and the variant that infected them.

 

“What happens with natural infection is that if you have a mild infection, you may not mount the strong cellular immune response that you need to fight it in the future,” Gandhi said. On the other hand, vaccines were subject to rigorous trials and found to elicit a high immune response. Most experts agree that a vaccine is a more quantifiable, predictable and reliable way to protect the population.

 

Another downside to relying on natural immunity is that Omicron has replaced Delta as the dominant variant, and Omicron is both more transmissible and more capable of evading immune protection triggered by both vaccines and previous infections.

 

Shane Crotty, a virologist and professor at La Jolla Institute for Immunology, told Yahoo News that the Omicron variant changed everything. “Omicron is looking so different from the other variants that just infection alone might not be giving you great antibodies against the other variants because it looks so different,” he said. It is still unclear how much immunity one can expect to come out of an Omicron infection, including how long that protection lasts and whether it will apply to future variants.

 

Based on the epidemiological data available, Crotty said, those who are likely to be the most protected against both infection and hospitalization at the moment are people who have had a breakthrough infection. This means, individuals who have had an infection and then a vaccine, or vice versa.

 

“Data by tons of labs shows that those people make really broad neutralizing antibodies,” the professor said. “Their antibodies recognize every possible variant and even distant viral species, but they also make really high levels of those antibodies,” he added.

 

People in this category — both infection and vaccination — have what has become to be known as “hybrid immunity” or “super immunity.” According to a CDC study, those who get fully vaccinated after recovering from COVID-19 have twice the protection of those who do not get vaccinated after their recovery.

 

Experts warn, however, this doesn’t mean people should purposefully try to infect themselves with the coronavirus to achieve greater protection against COVID-19, since there are serious health risks involved.

 

People who are boosted also have an especially high level of protection against Omicron. “It’s pretty amazing three doses of the same vaccine, which is just against the ancestral strain. Your immune system is so clever. It’s seeing that old version of the spike protein basically, and the first two times it sees it, it makes neutralizing antibodies against the ancestral strain and a couple of variants, but not Omicron, but just seeing that same vaccine the third time, and now you make neutralizing antibodies against Omicron,” Crotty explained.

 

Underscoring the value of a third dose, recent studies by the CDC have shown a booster dose of the COVID-19 vaccine significantly reduces a person’s chance of hospitalization from the Omicron variant. One of the CDC reports, which looked at 259 hospitals and 383 emergency departments from late August through early January, found that a third dose of either the Pfizer or Moderna vaccine was 90 percent effective at preventing hospitalization and 82 percent effective at preventing emergency department and urgent care visits.

 

However, despite the evidence supporting the efficacy of a third dose, many Americans have been hesitant to receive their booster shots. Gandhi says this is unfortunate because boosters could be the ticket back to normal, and those who are unboosted or unvaccinated are more vulnerable to Omicron and future variants that could emerge. “What we need to get through this time is immunity ... so even if you’ve been actually infected, I really would recommend at least one dose of a vaccine,” Gandhi said.

 

www.vox.com/coronavirus-covid19/22841229/covid-19-us-canc...

 

Covid-19 created America’s next health care crisis: The cancers we didn’t catch early

 

The pandemic dramatically disrupted cancer screenings, and thousands of lives are now at stake.

 

Steve Serrao, chief of gastroenterology at a hospital in Moreno Valley, California, just lived through the fourth wave of Covid-19 with the omicron variant sweeping across the country. Patients in respiratory distress once again filled the hospital’s beds.

 

But it is another wave, one that’s starting to trickle in but is still a long way from cresting, that Serrao worries about most. He fears that the delayed diagnoses of various cancers and other chronic, life-threatening illnesses — the result of Covid-19’s disruption to routine checkups and screenings — will be the next crisis that overwhelms the US health system.

 

“Our next surge will be advanced chronic disease,” Serrao told me over the phone. “That’s going to be the next surge of patients who overwhelm our system. I don’t think our systems are ready.”

 

The Covid-19 pandemic dealt a crushing blow to the preventive services that can catch potential health problems before they become life-threatening. Screenings for several major cancers fell significantly during 2020, according to a study published in December 2021 in the journal Cancer. Colonoscopies dropped by nearly half compared to 2019, prostate biopsies by more than 25 percent. New diagnoses declined by 13 percent to 23 percent, depending on the cancer — not because there was less cancer in the world, but because less of it was being detected. The screening backlog was still growing by the end of 2020, according to this recent study, albeit at a slower rate.

 

“I think we are absolutely in uncharted territory,” Brian Englum, a University of Maryland surgeon who co-authored the new Cancer study, told me. “There are no examples I know of where we have seen numbers change this dramatically.”

 

The fear among doctors is that the pandemic’s disruption to cancer screenings and other preventive measures won’t just be a blip, although a blip would be bad enough on its own: When cancer gets diagnosed late, it’s less likely a patient’s doctors can successfully intervene, and the patient is more likely to die. Even a four-week delay in diagnosis is associated with a 6 to 13 percent higher risk of death.

 

But they also fear that the missed screenings will lead to a more permanent disconnect between patients and the health system. Research has found that when patients lose their primary care doctor, they tend to end up in the hospital more, with more serious health problems. People who have skipped appointments or didn’t get screenings or care may be less likely to seek it in the future, and the problems could compound.

 

It may take years for the consequences to become clear. Before the pandemic, some physicians questioned if the US might be conducting too many screenings. But the country is now being forced to undergo an unintended natural experiment in less screening, one with thousands of lives at stake. The collateral damage of a pandemic that has killed more than 900,000 Americans could grow even more.

 

“We could be years into this before we know there’s a problem,” Englum said, “and we’ve already lost a lot of people.”

 

“How many of these cases are out there? Nobody knows.”

 

Serrao described one of his patients as a Hispanic man in his 40s. When he first noticed bleeding in early 2020, the patient talked to his primary care doctor, who told him it might be hemorrhoids, Serrao said. The primary care doctor acknowledged that getting a cancer screening would be impossible on short notice because the local hospitals were so strained with Covid-19. And the patient feared he might get sick if he went to a hospital.

 

Ultimately, it was 18 months before the patient sought a colonoscopy. He was diagnosed with what was, by then, advanced rectal cancer, Serrao said.

 

If the man had come in right away, Serrao said, he might have been cancer-free after a simple polyp removal. Instead, the doctor and his team are now battling cancer that has moved into other parts of the patient’s body. His outlook is much worse than it would have been if the cancer had been caught sooner.

 

“How many of these cases are out there? Nobody knows,” Serrao said.

 

Serrao’s patient had the misfortune to notice symptoms amid the biggest disruption of medical care in US history — one that hit cancer screenings particularly hard. In April 2020, as many hospitals canceled services in order to prepare for the expected surge of Covid-19 patients, the number of colonoscopies plummeted 93 percent. Then, after a brief rebound, the late 2020 winter wave stretched hospitals and forced them to limit services. By the end of the year, there had been 133,231 fewer colonoscopies performed in 2020 compared to the 2019 baseline, 62,793 fewer chest CT scans, and 49,334 fewer fecal blood tests.

 

“The drop-off in screenings has made me born again on the importance of screening,” John Marshall, chief of oncology at Georgetown University Hospital, told me. “We’re seeing more advanced diagnoses, and people presenting at a stage where they no longer can be cured.”

 

It will take months for the backlog to be cleared. Carrie Saia, the CEO of a community hospital in Holton, Kansas, told me that one of her facility’s gastroenterologists had been recruited by a larger Kansas City hospital to “scope from 7 in the morning to whenever at night, doing nothing but scopes.”

 

“They’re 1,000 people behind and backlogged right now,” Saia said. “A certain percentage out of those patients are going to have cancer growing.”

 

And working to clear that backlog begets a new backlog. Patients who are just now seeking a screening are finding it harder to get appointments. Marshall said he knew of patients who first experienced symptoms in September, were recommended for a screening by their doctor, but still couldn’t get an appointment as of December because there are so many patients in need of colonoscopies, MRIs, and other screening procedures.

 

Covid-19 led to direct rationing in overwhelmed hospitals last summer; they were unable to take patients with acute medical emergencies and couldn’t find another facility to take them. But this more subtle kind of rationing — delaying necessary services for months because the backlog has grown so large — also takes its toll, forcing doctors to make hard choices about which patients to prioritize.

 

“Everything is harder,” Marshall said. “We’ve had to make trade-off and priority decisions about who’s getting the treatment before the other person, decisions we would never have had to make.”

 

Covid-19’s disruption of US health care is likely going to deepen disparities

 

Serrao practices at the Riverside University Health System in San Bernardino County, about an hour and a half drive from downtown Los Angeles. Roughly two-thirds of his patients are Black, Hispanic, or Asian/Pacific Islander. Almost all of them have government insurance, either Medicare or Medicaid.

 

Black Americans already experience a higher incidence of and a higher mortality from colorectal cancers than white Americans. Black and Hispanic patients also tend to be diagnosed with more advanced lung cancers than their white peers, they have higher mortality from breast cancer, and they receive fewer prostate exams. At each stage, from preventive screenings to death rates, disparities already existed.

 

“They already have health disparities on a good day,” Serrao told me. “These last couple of years have put them back multiple years. The setback is quite profound.”

 

Over the course of the pandemic, Serrao’s practice struggled to make a dent in the backlog. Just as they would gain some momentum, another surge of Covid-19 would interrupt their progress.

 

Last January, the GI unit at his hospital was converted to a recovery area for patients receiving radiation therapy and other cancer treatments because overflow Covid-19 patients were in the space usually reserved for oncology recovery patients. As a result, he and his team couldn’t perform any screenings.

 

It was a necessary step — the top priority was maintaining treatment for patients already diagnosed with cancer — but it required the postponement of screenings to identify new cancer cases. The backlog got bigger.

 

“I’m almost certain that there are population pockets out there that have high disparities with cancer that will show up in the next year, two years, three years with more advanced cancers,” Serrao said, “and that’s because of the disruption in health care.”

 

The US will be living with the fallout of delayed cancer screenings for years

 

That problem may only be getting worse over time. Englum told me that one of the more troubling implications of their findings is that cancer screenings did not return to their pre-pandemic normal by the end of 2020.

 

It wasn’t a two- or three-month blip during the worst of the outbreak. By the end of the year, the drop in screenings looked more and more like a permanent setback. It’s the same problem we’re seeing with routine vaccinations: people who missed their shots and aren’t catching up even as we enter a new post-Covid normal.

 

“What our study shows is not only did we not make up for the blip, we didn’t even get back to baseline by the end of 2020,” Englum said. “We kept losing ground.”

 

The US health system struggled before the pandemic with managing people’s care in a timely fashion. It requires having an established relationship with a primary care doctor — which fewer and fewer Americans do — and then staying on schedule with recommended preventive screenings like colonoscopies and mammograms. As of 2018, according to a federal study, only 8 percent of Americans were receiving all the preventive services that are recommended for them.

 

Americans have now lived through two years when their primary care practice might have been closed, permanently or temporarily. The hospitals where they would have gotten a colonoscopy were postponing those non-emergent procedures. Some of them may have been afraid to go to the doctor or hospital, knowing that a highly transmissible virus was on the loose.

 

That only makes the challenge of getting people to stay on top of their health care harder. Doctors worry that people’s habits may be permanently changed by the pandemic — and not for the better.

 

“I am fearful that once people got out of that habit, they didn’t see an immediate problem,” Englum told me. “Then they say, ‘Well, I haven’t seen my doctor for six months or a year and nothing happened. I feel fine.’ They’re just out of the habit. They lost the routine.”

 

That means the health system is flying blind. Unless people get back in the habit of getting their recommended screenings, doctors will lose ground every year in identifying patients with serious conditions or at risk of developing them. That would limit their ability to get ahead of emerging health problems before they become chronic or even life-threatening.

 

In theory, Englum pointed out, this also could be an opportunity to learn whether the current screening guidelines are actually appropriate. If 10 years were to pass and there were no appreciable increase in cancer mortality, for example, maybe we could revise our recommendations for colonoscopies from every 10 years to every 12. The pandemic would have provided evidence such a delay doesn’t present a big risk at the population level.

 

That kind of reevaluation is happening across the health system. Health insurers are monitoring the outcomes for patients who delayed kidney treatment because of Covid-19. They are watching for any negative effects, but also for countervailing evidence that might indicate the missed care was actually unnecessary.

 

At every level, the pandemic has forced a natural experiment in what a disruption to the usual treatment plan means for patient outcomes. We are going to learn a lot, like it or not. The risk is that those lessons will come at the cost of thousands of lives.

 

Because the flip side of the optimistic scenario is that in 10 years’ time, we will see cancer mortality increasing as a result of delayed screenings.

 

“By then,” Englum said, “you’ve lost the opportunity to treat however many thousands of people.”

Dr. Shawn Khodadadian is an anal warts removal specialist doctor in NYC. Manhattan Gastroenterology is now offering safe and effective anal wart removal at our offices. Dr. Jeffrey Aronoff, a board certified, renowned colorectal surgeon works with our award winning gastroenterologists when treatment is needed.

 

Manhattan Gastroenterology

983 Park Ave, Ste 1D

New York, NY 10028

(212) 427-8761

www.manhattangastroenterology.com/

 

Herbert Gaisano, Toronto - professor and researcher at the University of Toronto's faculty of medicine and one of the world's leading gastroenterologists.

He has dedicated his work to the fight against diabetes by exploring the complexities of this pervasive illness and advancement of new treatment strategies.

 

Herbert Gaisano, Toronto - professeur et chercheur à la faculté de médecine de l'université de Toronto et l'un des principaux gastro-entérologues du monde.

Il a consacré son travail à la lutte contre le diabète en explorant la complexité de cette maladie très répandue et en faisant la promotion de nouvelles stratégies de traitement.

British Columbia’s provincewide colon cancer screening program is moving forward with the availability of a new, easy-to-use test that will help save lives by supporting the early detection of colorectal cancer.

 

L to R -

Minister of Aboriginal Relations and Reconciliation Ida Chong who attended on behalf of Minister of Health Margaret MacDiarmid Deb Imada, colorectal cancer survivor and Colorectal Cancer Association of Canada volunteer Claire Cross Dr. Denis Petrunia, Victoria gastroenterologist Dr. Max Coppes, BC Cancer Agency president

 

Learn more: www.newsroom.gov.bc.ca/2013/04/bcs-colon-cancer-screening...

Facility in KKasturi Hospital at Mira Bhayandar

 

Operation Theater:

Our major operation theatre has now been renovated to state of art international standard operation theatre with laminar air flow system. Now our operation theatre meets Indian as well as international standards for joint replacement surgeries & supra major plus surgeries.

 

About KKasturi Hospital

---------------------------------

KKASTURI MEDICARE PVT. LTD. located at Mira Bhayandar has 60 bedded indoor facility with Polyclinic, Diagnostic Centre, ICCU, NICU, Dialysis Unit, Pediatric, Surgical, Maternity & General Hospital that meets the standards of “One Stop Hi - Tech Centre. ” We believe in Health Care.... Human Care"

 

We also offer Medical Tourism for our International Patients

 

For more detail about KKasturi Hospital in Mira Bhayander Visit www.kasturihospital.com

 

Two full fledged well equipped operation theatres with hydraulic radiolucent C-ARM compatible operation tables, bipolar underwater cutting cautery machine, boyles apparatus, ventilators, cardiac monitor, pulse oxymeter, suitable for major, supramajor, laparoscopic, orthopaedic, endoscopic & high risk surgeries. Minor operation theatre is on ground floor. Major operation theatre is on the first floor.

www.yahoo.com/lifestyle/phones-toilet-just-dont-sit-18081...

 

We all use phones on the toilet. Just don't sit more than 10 minutes.

 

Let's get this out of the way upfront: Plenty of people use portable devices - phones, chiefly, but also mobile gaming consoles like the Nintendo Switch and the Steam Deck - while on the toilet. There's a good chance, in fact, that you're reading this article on the toilet.

 

Incredibly, a few surveys have been conducted on the subject. In one conducted by NordVPN earlier this year, 65 percent of respondents (of 9,800 adults surveyed) said they used their phones in the bathroom. But it also just feels anecdotally true. The habit isn't a new one; people have kept books and magazines by the porcelain throne for decades. With ever-smaller and more portable devices in our pockets, it seems intuitive that we would turn to those devices in a quiet moment.

 

"Look, there are two types of people in the world," said Nir Eyal, an author and lecturer who writes about habits, focus and human behavior. "People who check their phone in the bathroom, and people who lie about checking their phone in the bathroom."

 

The practice is normally kept behind locked bathroom doors and left politely undiscussed. But in October, there was a vibe shift, brought about by the release of "Marvel Snap," a new card game available on phones and tablets. "Marvel Snap is the best game to play on the toilet currently," tweeted popular streamer and content creator Saqib "Lirik" Zahid to his almost 650,000 followers. "I hate Marvel Snap and so does my toilet seat," blared a headline on the video game website VG247. And although full disclosure may not be desired by readers of an article like this one, I feel compelled to say: I too play "Marvel Snap" on the toilet. I'm Spartacus!

 

Which prompted the question: Is it healthy to sit on the toilet with a phone? I turned to a gastroenterologist for answers.

 

"You generally don't want to spend more than about on average about 10 minutes," said Dr. Roshini Raj, a gastroenterologist at NYU Langone, and the author of "Gut Renovation," a book about digestive health. Though Raj acknowledged that - like with many things in medicine - there's not a one size fits all answer, she pointed to three potential pain points for preoccupied poopers.

 

First, sitting for prolonged periods of time could lead to hemorrhoids, sometimes-painful swollen veins in the anal area. Some of that comes down to the unique functional design of the toilet.

 

"There's a hole in the middle," Raj said. "And so the actual anal rectal area is hanging a little bit lower than the part that's supported - your thighs. Just by that position, gravity is causing everything to hang a bit, and that is causing pressure on the veins. So even if you're not straining, if you're just sitting there thinking of something else, doing something else, there is some pressure being applied to those veins."

 

More subtly, there's also the risk of your body starting to ignore its own signals. Peristalsis is the name for the progressive contractions that move stool through the intestine to the rectum. But sitting on the toilet for long periods of time not doing anything can hinder that process.

 

"If you're sitting for too long and not going to the bathroom, that kind of process actually stops," Raj said. "Your body can start to not recognize those signals as well, so it can lead to constipation if you're sitting for prolonged periods of time on the toilet without actually having a bowel movement." This risk, Raj noted, is more likely to be one of many factors in issues like constipation, rather than the driving force.

 

Then there's the most obvious factor: bathrooms can be gross. Research shows that a toilet flush can aerosolize pathogens, spreading them to nearby surfaces. That can include your phone, if you rest it on a sink by the toilet, for example. But even beyond aerosolized bacteria, there are risks posed by plain old bad hygiene.

 

"I see a lot of people who get food poisoning or catch different things by not having good hygiene practices in the bathroom," Raj said. If you're playing video games or using your phone on the toilet, you're probably touching a lot of things you might not want on your device. "I just think generally speaking, if you're on the toilet having a bowel movement or trying to have a movement, you shouldn't be using your fingers on anything else."

 

If you're staying within healthy time limits and - crucially - always maintaining good personal hygiene, your behavior probably doesn't need to change. But if you'd like to make a change, there are some simple ways to go about it.

 

For starters, don't assign a moral valence to staying in the bathroom for too long, cautioned Eyal, the author and lecturer. The rumination on the behavior can be "more mentally damaging for our mental health than the behavior itself," he said. Just be intentional about your behavior, setting plans for what you do in certain settings.

 

"There's nothing wrong with taking your phone to the bathroom for a few minutes and doing your business and then coming out," Eyal said. "But if you said, 'Oh, I planned to be with my kids, but now I stayed in the bathroom for 30 minutes scrolling on TikTok or Instagram,' well, now you're distracted, because you planned to do something and now you're not doing it. So that's the best piece of advice: to know what you wanted to do with your time so that you have a priority to spend your time doing that thing, rather than wasting it in the bathroom."

 

It's also important to remember: phones and other mobile devices aren't inherently bad, nor are they insurmountably distracting. If you find yourself perpetually losing track of time, consider whether you're attuned to bigger stressors in your life, and to how you're feeling in general.

 

"90% of the time that we get distracted by our phones in particular is because of what's happening inside of us," Eyal said. "Boredom, loneliness, fatigue, uncertainty, stress, anxiety. These sensations lead us to look for escape from our present reality. And so one of the important things to do with this problem, just like any distractions, is to ask ourselves: What am I escaping when I go to the bathroom for 30 minutes? What feeling am I trying to not feel by hanging out on my phone[?] . . . Is it my kids are driving me crazy? Is it work is too hard? Is it that I'm bored, I'm listless, I'm stressed, and now I can take my mind off of those problems?

 

"The fact of the matter is, if we don't deal with that, if we don't know how to deal with that in a healthy manner, I think we will always find a distraction."

 

So remember: Think about how you're spending your time, and wash your hands. And if you're playing "Marvel Snap," do no more than two matches if you're doing number two.

KASTURI MEMORIAL HOSPITAL located at Bhayander (West) was started in August 2001 and is now known as KKASTURI MEDICARE PVT. LTD. W.E.F 1/4/09.

 

KKASTURI MEDICARE PVT. LTD. has 60 bedded indoor facility with Polyclinic, Diagnostic Centre, ICCU, NICU, Dialysis Unit, Pediatric, Surgical, Maternity & General Hospital that meets the standards of “One Stop Hi - Tech Centre.

 

” We believe in Health Care.... Human Care"

 

KKASTURI MEDICARE PVT. LTD. is an exclusive hospital building (Ground + 3 Floors) with adequate parking facility, stretcher lift and round the clock availability of doctors of various specialties and super specialties to cater to routine and emergency cases.

 

Our Hospital is having continuous surveillance system in the form of CCTV Cameras in and around the hospital with recording system. CCTV Cameras are installed in waiting area lobbies of all floors.

 

To know more about KKasturi Multi Speciality Hospital in Mira Bhayandar visit www.kasturihospital.com

'Joining The Dots: Translational Research in Child Health Academic Centre for Paediatric Research at UCD Students Centre, Belfield. Pictured is Dr. Seamus Hussey, Paediatric Gastroenterologist, OLCH Crumlin.

Picture Colm Mahady / Fennells - Copyright 2014 Fennell Photography

All general wards have spaciously placed beds, attached toilet and bathroom, intercom facility & wooden partitions.

 

7 bedded female general ward

8 bedded male general ward.

4 twin sharing rooms.

5 non A/C special rooms

3 deluxe rooms with A/C and attached toilet.

4 super deluxe rooms with A/C and attached toilet.

 

About KKasturi Hospital

---------------------------------

KKASTURI MEDICARE PVT. LTD. located at Mira Bhayandar has 60 bedded indoor facility with Polyclinic, Diagnostic Centre, ICCU, NICU, Dialysis Unit, Pediatric, Surgical, Maternity & General Hospital that meets the standards of “One Stop Hi - Tech Centre.

 

” We believe in Health Care.... Human Care"

 

We also offer Medical Tourism for our International Patients

 

For more detail about KKasturi Hospital in Mira Bhayander Visit www.kasturihospital.com

The Indian Association for Parenteral and Enteral Nutrition (IAPEN) is an organization in the field of parenteral and enteral nutrition and promotes basic research, clinical research, advanced education, organization of consensus statements about clinical care and quality control.

 

The IAPEN Gastrointestinal Nutrition Congress - 2018 is hosted and organised by Department of Surgical Gastroenterology, JIPMER and Department of Dietetics, JIPMER in collaboration with IAPEN – Pondicherry Regional Centre on 2nd and 3rd February 2018 at Academic Centre, JIPMER, Dhanvantri Nagar, Gorimedu, Puducherry 605 006.

 

Website: www.iapen.co.in/gi-nutrition/

 

The conference aims at bringing together gastroenterologists, surgeons, anesthesiologist, intensivists, dietitians and nutrition support clinicians to improve health through better nutrition and advanced education. This will catalyze promotion of inter-sectoral coordination, so as to arrive at comprehensive and sustainable strategies to address the problems faced in Nutrition Support for critically ill Patients.

 

The Organizers, Delegates and Media participated in this event made history as it is considered to be the first of its kind event on Gastrointestinal Nutrition in the Entire World till 2018.

Robynne Chutkan

Founder, Digestive Center for Wellness; Gastroenterologist

 

Rob Knight

Professor, Departments of Pediatrics, Bioengineering, and Computer Science & Engineering, University of California, San Diego

 

Julie DiBiase

Chief Content Officer, Prostate Cancer Foundation

 

Karen Sandell Sfanos

Associate Professor, Department of Pathology, Oncology, and Urology, Johns Hopkins University School of Medicine

 

Josh Stevens

President and Chief Commercial Officer, DayTwo

Day Sixty-Eight ~ At School

 

Dominic was supposed to ride the bus home but I got a call from him saying he had missed the bus. I was already in town (buying him an entire new spring/summer wardrobe because he has outgrown everything from last fall), so I went over to pick him up. It gave me a great opportunity to get this photo in front of his school. Unfortunately, he had gotten into a fight with another boy and his knees got a little roughed up after taking a tumble. He will have to serve a half-day in ISS later in the week. The last couple of weeks have been a bit harder for him, I hope things start looking up again soon.

 

Dominic’s blood work came back. Everything was normal except there was a slight elevation in the wheat category, so he has a mild allergy/sensitivity to wheat. I guess a visit with the pediatric gastroenterologist is next.

Manhattan Gastroenterology

170E 78th St,

New York, NY 10075

(212) 427-8761

manhattangastro@gmail.com

manhattangastroenterology.com

 

We are proud to offer state of the art medical, gastroenterology and endoscopy services with a personalized touch in the heart of the upper east side of Manhattan (NYC). Through our integrative approach, we pride ourselves on spending the time necessary to analyze and treat difficult digestive issues that can often be overlooked in today's fast paced health care environment. We understand that you need an experienced gastroenterologist you can trust and that is the focus of our practice. In our facility, we utilize the latest technological advancements to diagnose and treat conditions in their earliest stages. Our goal is to build a family of satisfied and cared-for patients that we can watch live happy, healthy and productive lives.

 

At Manhattan Gastroenterology, we strive to make our office as efficient and convenient as possible. Call us with any questions at (212) 427-8761.

 

Working Hours: Mon - Fri 8am - 6pm

Payments Accepted: Cash, Credit Cards

Opened Since: 2001

 

Twitter: twitter.com/ManhattanGastro

Facebook: www.facebook.com/pages/Manhattan-Gastroenterology/1610001...

Blogger: manhattangastroenterology.blogspot.com/

Robynne Chutkan

Founder, Digestive Center for Wellness; Gastroenterologist

 

Rob Knight

Professor, Departments of Pediatrics, Bioengineering, and Computer Science & Engineering, University of California, San Diego

I've been joking with my friends that with Easter approaching, I was having post traumatic stress flashbacks. Last Easter Olive was 10 weeks old and I'm pretty certain it was both when we hit rock bottom and when things started to turn around the tiniest of bits.

 

She weighed a little over 8 pounds and her reflux was getting worse. She rarely slept anywhere but on one of us. I remember the next week asking her new gastroenterologist if it was normal for a baby to cry so much. I tried to sound nonchalant when I squeaked out, "We have to hold her when she's awake or she'll cry. That can't be what normal babies do, right?"

 

Of course the doctor told us politely that all babies were different. No comfort to this mama who was nearing the end of her rope. Before we left for Marion, Olive and I had reached a nursing regression. What had become pretty comfortable and routine now was something that was painful and that I dreaded. I thought that once you got over that first month, nursing was no longer a struggle. No one had warned me that there would be setbacks and frustrations along the way.

 

For our trip to my parent's at Easter, I went out and bought a Rock n' Play because I heard it was a miracle worker and I really needed a miracle. It didn't help our "sleep only on a living being" nap situation but it did give us much better nighttimes. And best of all, she wasn't waking up to crib sheets covered in spit up.

 

But the one thing I'll always remember about last Easter is my mom and I getting into a near argument about what sort of baby Olive was. Grandmom said she was somewhere between "textbook and angel". I said she was grumpy and high needs. I guess my mom saw Olive's potential and knew what the future held.

 

A few weeks later Olive was on a new reflux regimen. She stopped spitting up quite so much. She could tolerate a little more solo time. She stopped taking every nap on us. We made mom friends. And just a month later she was unbelievably more happy, smiled all the tim and was always ready to play or be read to. It all changes so fast.

 

A year ago I could not have envisioned this Easter. Our happy, beautiful daughter playing in the sun, splashing in her water table, digging through her basket. She runs from room to room. She walks up to everyone, tilts her head, waves her hand and says "HI!" She signs and says stop and then a few seconds later yells "Goooooooooooo!"

 

I was overwhelmed this year with gratitude. Lucky to have such an amazing daughter who makes our lives so much richer. Thankful to have a fabulous husband who is also a great father. Awed to have grandparents who are so involved in our life and who love Olive so very much. My dad worked for weeks to clean out my brother's old room and make a nursery for Olive. My mom put together the cutest basket ever for her and had lots of her favorite foods on hand. My brother and his family made the long drive from Atlanta to be part of Olive's second Easter.

 

We are lucky beyond description. If you ever have a baby, and find that those first few months are harder than you expected. Or that maybe you didn't get the baby you had imagined. Don't be fooled into thinking that your today is also your future. Your future will surprise you in the most wonderful ways.

Manhattan Gastroenterology

170E 78th St,

New York, NY 10075

(212) 427-8761

manhattangastro@gmail.com

manhattangastroenterology.com

 

We are proud to offer state of the art medical, gastroenterology and endoscopy services with a personalized touch in the heart of the upper east side of Manhattan (NYC). Through our integrative approach, we pride ourselves on spending the time necessary to analyze and treat difficult digestive issues that can often be overlooked in today's fast paced health care environment. We understand that you need an experienced gastroenterologist you can trust and that is the focus of our practice. In our facility, we utilize the latest technological advancements to diagnose and treat conditions in their earliest stages. Our goal is to build a family of satisfied and cared-for patients that we can watch live happy, healthy and productive lives.

 

At Manhattan Gastroenterology, we strive to make our office as efficient and convenient as possible. Call us with any questions at (212) 427-8761.

 

Working Hours: Mon - Fri 8am - 6pm

Payments Accepted: Cash, Credit Cards

Opened Since: 2001

 

Twitter: twitter.com/ManhattanGastro

Facebook: www.facebook.com/pages/Manhattan-Gastroenterology/1610001...

Blogger: manhattangastroenterology.blogspot.com/

Manhattan Gastroenterology

170E 78th St,

New York, NY 10075

(212) 427-8761

manhattangastro@gmail.com

manhattangastroenterology.com

 

We are proud to offer state of the art medical, gastroenterology and endoscopy services with a personalized touch in the heart of the upper east side of Manhattan (NYC). Through our integrative approach, we pride ourselves on spending the time necessary to analyze and treat difficult digestive issues that can often be overlooked in today's fast paced health care environment. We understand that you need an experienced gastroenterologist you can trust and that is the focus of our practice. In our facility, we utilize the latest technological advancements to diagnose and treat conditions in their earliest stages. Our goal is to build a family of satisfied and cared-for patients that we can watch live happy, healthy and productive lives.

 

At Manhattan Gastroenterology, we strive to make our office as efficient and convenient as possible. Call us with any questions at (212) 427-8761.

 

Working Hours: Mon - Fri 8am - 6pm

Payments Accepted: Cash, Credit Cards

Opened Since: 2001

 

Twitter: twitter.com/ManhattanGastro

Facebook: www.facebook.com/pages/Manhattan-Gastroenterology/1610001...

Blogger: manhattangastroenterology.blogspot.com/

Manhattan Gastroenterology

170E 78th St,

New York, NY 10075

(212) 427-8761

manhattangastro@gmail.com

manhattangastroenterology.com

 

We are proud to offer state of the art medical, gastroenterology and endoscopy services with a personalized touch in the heart of the upper east side of Manhattan (NYC). Through our integrative approach, we pride ourselves on spending the time necessary to analyze and treat difficult digestive issues that can often be overlooked in today's fast paced health care environment. We understand that you need an experienced gastroenterologist you can trust and that is the focus of our practice. In our facility, we utilize the latest technological advancements to diagnose and treat conditions in their earliest stages. Our goal is to build a family of satisfied and cared-for patients that we can watch live happy, healthy and productive lives.

 

At Manhattan Gastroenterology, we strive to make our office as efficient and convenient as possible. Call us with any questions at (212) 427-8761.

 

Working Hours: Mon - Fri 8am - 6pm

Payments Accepted: Cash, Credit Cards

Opened Since: 2001

 

Twitter: twitter.com/ManhattanGastro

Facebook: www.facebook.com/pages/Manhattan-Gastroenterology/1610001...

Blogger: manhattangastroenterology.blogspot.com/

About KKasturi Hospital

---------------------------------

KKASTURI MEDICARE PVT. LTD. located at Mira Bhayandar has 60 bedded indoor facility with Polyclinic, Diagnostic Centre, ICCU, NICU, Dialysis Unit, Pediatric, Surgical, Maternity & General Hospital that meets the standards of “One Stop Hi - Tech Centre. ” We believe in Health Care.... Human Care"

 

We also offer Medical Tourism for our International Patients

 

For more detail about KKasturi Hospital in Mira Bhayander Visit www.kasturihospital.com

 

Our tiny Olive weighed in at 8 pounds, 8 ounces at her doctor's appointment this week. The nurses made fun of her for still wearing newborn diapers but said that she'd grow to be petite but smart. She's in the 50th percentile for head circumference and the second (2!!!) percentile in weight. She still wears newborn clothes though she's getting too long for her footed rompers. Sadly, her reflux is flaring back up and her regular pediatrician sent us to a pediatric gastroenterologist. We're upping her dosage of reflux meds and hoping that things turn around at the three month mark. She's so smiley and playful in the morning; it's a welcome glimpse of who she is when she's not miserable from tummy trouble.

www.youtube.com/watch?v=-tNjUlVZiLw

 

New Covid-19 subvariants can reinfect Omicron-recovered patients, early studies find

 

www.cnn.com/2022/05/06/health/hepatitis-kids-cdc-update/i...

 

CDC investigating more than 100 cases of unexplained hepatitis in children, including 5 deaths

 

(CNN) The US Centers for Disease Control and Prevention said Friday that it's investigating 109 cases of severe and unexplained hepatitis in children in 25 states and territories that may be linked to a worldwide outbreak.

 

Among them, 14% needed transplants, and five children have died.

 

Nearly all the children -- more than 90% -- needed to be hospitalized.

 

Dr. Jay Butler, the CDC's deputy director of infectious diseases, stressed that the investigation -- a partnership between the CDC and state health departments -- is an evolving situation. Not all the hepatitis cases they are studying now may ultimately be caused by the same thing.

 

"It's important to note that this is an evolving situation, and we are casting a wide net to help broaden our understanding," Butler said.

 

Hepatitis, or swelling of the liver, can be caused by infections, autoimmune diseases, drugs and toxins. A family of viruses well known for attacking the liver causes hepatitis A, hepatitis B and hepatitis C.

 

It's not clear what's driving these cases in young children. Butler said some of the common causes of viral hepatitis have been considered but were not found in any of the cases.

 

Adenovirus has been detected in more than 50% of cases, although its role isn't clear.

 

Early hepatitis reports

On April 21, the CDC alerted doctors to a cluster of unusual cases of hepatitis in nine children in Alabama.

 

It asked doctors and public health officials to notify the agency if they had similar cases of children under the age of 10 with elevated liver enzymes and no apparent explanation for their hepatitis going back to October.

 

Since then, health departments have been working with pediatric specialists in their states to identify possible cases. The numbers shared at Friday's news briefing are the first national look at cases.

 

Cases are under investigation in Alabama, Arizona, California, Colorado, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Louisiana, Michigan, Minnesota, Missouri, North Carolina, North Dakota, Nebraska, New York, Ohio, Pennsylvania, Puerto Rico, Tennessee, Texas, Washington and Wisconsin.

The CDC's alert followed reports of children from England, Wales, Scotland, and Northern Ireland going to hospitals with unexplained hepatitis.

 

As of May 1, there are 228 probable cases linked to the outbreak in 20 countries, with more than 50 cases under investigation, Dr. Philippa Easterbrook, a senior scientist in the World Health Organization's Global Hepatitis Program, said in a briefing Wednesday. Among these cases, one child has died, and about 18 have needed liver transplants, she said.

 

Most of the children were healthy when they developed symptoms that included fatigue, loss of appetite, vomiting, diarrhea, belly pain, dark urine, light-colored stools and yellowing of their skin and eyes -- a sign called jaundice.

Unusually severe liver inflammation

 

Pediatric gastroenterologist Dr. Heli Bhatt of M Health Fairview Masonic Children's Center in Minneapolis has treated two children who are part of the CDC's investigation. One, a 2-year-old from South Dakota, had a liver transplant this week.

Bhatt says liver failure in kids is "super rare." And even before scientists started tracking this outbreak, half of cases were never explained.

 

Doctors who have treated these children say their cases stood out.

 

"Even during the first case, I thought it was weird," says Dr. Markus Buchfellner, a pediatric infectious disease specialist at the University of Alabama at Birmingham, where staffers started seeing cases in October.

 

"And then when the second one came in, that's when I said, 'OK, we need to talk to someone about this.' " He reached out to senior physicians in his department, who contacted the state health department and the CDC.

 

Buchfellner says the cases stood out because the liver inflammation was so severe.

 

Sometimes, common viruses like Epstein-Barr or even SARS-CoV-2 will raise a child's liver enzymes a little, indicating what Buchfellner calls "small bits of hepatitis," but the kids typically recover as their bodies fight off the infection.

 

"But it's very odd to see a child who's healthy come in with the amount of liver injury that these kids had," he said.

 

Initially, UAB saw nine kids with unexplained hepatitis, and all nine tested positive for adenovirus in their blood. None of them tested positive for Covid-19 during their hospitalization or had a documented history of Covid-19, Butler said at the news briefing.

 

Since those cases were reported, two more children in Alabama have been identified. Their cases are under investigation, bringing the state's total to 11, said Dr. Wes Stubblefield, medical officer for Alabama's Northern and Northeastern Districts.

 

There are about 100 kinds of adenoviruses. About 50 of them are known to infect humans, so experts needed a closer look at the virus to try to figure out if all the children had the same one.

 

When researchers tried to read the genes of the adenovirus in infected kids, only five had enough genetic material to get a full sequence. In all five, the virus was a particular kind called adenovirus 41. It typically causes diarrhea and vomiting in kids, sometimes with congestion or a cough, but has never before been associated with liver failure in otherwise healthy children.

 

Butler said Friday that adenovirus 40 and 41 have been linked to hepatitis but almost exclusively in immunocompromised children.

 

Clues from the UK

Also Friday, researchers with the UK Health Security Agency posted a new technical briefing with an update on its hepatitis investigation. Of 163 cases, 126 patients have been tested for adenovirus, and 91, or 72%, were positive for that pathogen.

Investigators have tried to sequence the entire genome of an adenovirus from one of the patients but have not been able to get a sample with enough of the virus to do that. There were 18 cases in which where they were able to partially sequence the genome, and all of them have been adenovirus 41F, the same one found in the US cases.

 

Many have wondered whether the cases may somehow be related to SARS-CoV-2, the virus that causes Covid-19.

 

UK investigators say they're still looking at that possibility, but only 24 out of 132 patients tested -- 18% -- had SARS-CoV-2 detected.

 

The report says they are not ruling out some role for a Covid-19 infection in these cases. Perhaps a prior Covid-19 infection somehow primed the immune system to make these children unusually susceptible, or maybe a co-infection of the two viruses together overwhelms the liver.

 

Researchers also want to know if the hepatitis is part of some kind of syndrome that strikes kids after a SARS-CoV-2 infection, like the rare complication called multisystem inflammtory syndrome in children, or MIS-C.

 

Another working theory from UK investigators is that there's some kind of outsized or irregular immune response in these children, perhaps because they were sheltered more than usual during the pandemic.

 

Yet another theory is that the adenovirus may have always caused liver failure in a tiny percentage of children who were infected, and these rare cases are coming to light only because it is causing an exceptionally large wave of infections.

 

And investigators in the UK say they are still testing for drugs, toxins or perhaps an environmental exposure, even though some kind of infection is probably more likely to be the cause.

 

Sorting out the role of adenovirus 41

Another thing that's puzzled doctors, Buchfellner says, is that they found adenovirus in blood samples but not in samples of liver tissue taken during biopsies of the patients in Alabama.

"All nine of them have liver biopsies that were showing lots of inflammation and hepatitis. But we did not find the virus in the liver. We only found the virus in the blood," he said.

 

Bhatt's case, a child from South Dakota, was also positive for adenovirus in her blood but not in her liver.

 

If adenovirus 41 is somehow responsible in these cases -- and that's still a big if -- Buchfellner says he doesn't know why it would only show up in the blood but not in heavily damaged liver tissue. But he has some theories.

 

"Maybe the liver is clearing the virus before it's been cleared in the blood," he said. "And so by the time that the damage has been done to the liver and we do the biopsy, the immune system has already cleared the virus from the liver. And what's left over is just inflammation."

 

His second theory is that it's not the virus itself that's responsible for the liver damage, but perhaps the immune system overreacts when trying to fight off the virus and ends up damaging the liver.

 

Adenovirus infections are common, so maybe finding the virus in some of these patients is just a coincidence. "We are not 100% sure that this is just that adenovirus. There's still a lot to be known," Bhatt said.

 

Active investigation

In an April 29 statement on the cases, the CDC wrote, "we believe adenovirus may be the cause for these reported cases, but other potential environmental and situational factors are still being investigated."

 

Butler said Friday that experts are considering a range of possibilities, including exposure to animals.

 

"We really are casting a broad net and keeping an open mind in terms of whether the adenovirus data may reflect an innocent bystander or whether there may be cofactors that are making the adenovirus infections manifest in a way that's not been commonly seen before," he said.

 

Investigators say they know that this news may worry parents.

Butler says investigators still believe these cases are very rare. They have not seen an increase, for example, in children coming to emergency rooms with hepatitis.

 

"We are still telling at least our families here in Alabama -- and I would encourage other families the same way -- not to be too concerned about this just yet." Buchfellner said. "I mean, at the end of the day, this is still a pretty rare phenomenon."

 

Buchfellner says adenoviruses are commonly passed around day cares and schools. They typically cause nothing worse than something that feels like stomach flu for a few days.

"it's been around for a long time, and it's gonna continue to go around. And in total, we only have around 200 cases that have been reported across the globe. So this isn't a Covid pandemic-like situation where everybody needs to be really concerned about this," he said.

Robynne Chutkan

CEO, Gutbliss LLC; Integrative Gastroenterologist

 

Mark Hyman

Head of Strategy and Innovation, Cleveland Clinic Center for Functional Medicine

 

Rob Knight

Professor, Departments of Pediatrics, Bioengineering, and Computer Science & Engineering, University of California, San Diego

 

David Perlmutter

Executive Vice Chancellor for Medical Affairs and Dean, Washington University School of Medicine

 

Karen Sandell Sfanos

Associate Professor, Department of Pathology, Oncology, and Urology, Johns Hopkins University School of Medicine

Robynne Chutkan

CEO, Gutbliss LLC; Integrative Gastroenterologist

 

Mark Hyman

Head of Strategy and Innovation, Cleveland Clinic Center for Functional Medicine

 

Appropriate for a gastroenterologist, but I thought I left the shitty job at home!

Facilities at KKasturi Hospital in Mira Bhayandar

 

X- Ray :

 

1) 300 mA Siemens Machine with dark room fluoroscopy with 5 positions X-ray table to do all types of X-rays and procedures.

 

2) 100 mA mobile x-ray machine for doing emergency portable x-rays in ICCU, NICU and operation theatres.

 

3) 30 mA portable mobile X-ray machine for doing X-rays at home is also available.

 

About KKasturi Hospital

---------------------------------

KKASTURI MEDICARE PVT. LTD. located at Mira Bhayandar has 60 bedded indoor facility with Polyclinic, Diagnostic Centre, ICCU, NICU, Dialysis Unit, Pediatric, Surgical, Maternity & General Hospital that meets the standards of “One Stop Hi - Tech Centre. ” We believe in Health Care.... Human Care"

 

We also offer Medical Tourism for our International Patients

 

For more detail about KKasturi Hospital in Mira Bhayander Visit www.kasturihospital.com

Facility at KKasturi General Hospital in Mira Bhayandar

 

Pathology laboratory is headed by MD Pathologist Dr. Vijay Gupta and is semi automated having cell counter, biochemistry auto analyzer, automatic electrolyte machine, automatic ABG machine and round the clock availability of qualified, experienced lab technicians to do all types of pathology tests. We have tie-up with specialised labs like Metropolis Labs, DR Lal's Path lab, Thyrocare and Suburban Diagnostic. 24 hours Pathology facility is available. Home visit facility available.

 

About KKasturi Hospital

---------------------------------

KKASTURI MEDICARE PVT. LTD. located at Mira Bhayandar has 60 bedded indoor facility with Polyclinic, Diagnostic Centre, ICCU, NICU, Dialysis Unit, Pediatric, Surgical, Maternity & General Hospital that meets the standards of “One Stop Hi - Tech Centre. ” We believe in Health Care.... Human Care"

 

We also offer Medical Tourism for our International Patients

 

For more detail about KKasturi Hospital in Mira Bhayander Visit www.kasturihospital.com

From: Outpatients - green 'floral' folder, Royal Newcastle Hospital. Colour

This photograph is from the Hospital archives held by the University Archives in Cultural Collections, Auchmuty Library, the University of Newcastle, Australia.

 

This image can be used for study and personal research purposes. If you wish to reproduce this image for any other purpose you must obtain permission by contacting the University of Newcastle's Cultural Collections.

 

Please contact us if you are the subject of an image, or know the subject of the image, and have cultural or other reservations about the image being displayed on this website and would like to discuss this with us.

 

If you have any information about this photograph, please contact us or leave a comment in the box below.

Robynne Chutkan

CEO, Gutbliss LLC; Integrative Gastroenterologist

 

Mark Hyman

Head of Strategy and Innovation, Cleveland Clinic Center for Functional Medicine

 

Rob Knight

Professor, Departments of Pediatrics, Bioengineering, and Computer Science & Engineering, University of California, San Diego

 

David Perlmutter

Executive Vice Chancellor for Medical Affairs and Dean, Washington University School of Medicine

 

Karen Sandell Sfanos

Associate Professor, Department of Pathology, Oncology, and Urology, Johns Hopkins University School of Medicine

www.msn.com/en-us/health/wellness/farts-say-more-about-yo...

 

Farts say more about your health than you think — now, scientists are listening

 

As David Ancalle opened video after video of diarrhea this year, it struck him: This is not what he expected to be doing for his Ph.D.

 

Ancalle, a mechanical engineering student at Georgia Tech who researches fluid dynamics, is currently working to demystify the acoustics of urination, flatulence, and diarrhea. His team is training AI to recognize and analyze the sound of each bathroom phenomenon; in fact, research suggests that tracking the flow of our excretions could benefit public health.

 

What’s new — Ancalle and Maia Gatlin, an aerospace engineer at the Georgia Tech Research Institute (GTRI), created a mechanical device loaded with pumps, nozzles, and tubes meant to recreate the physics — and sounds — of human bodily function. They named it the Synthetic Human Acoustic Reproduction Testing machine (yep, S.H.A.R.T.).

 

S.H.A.R.T. is now preparing an AI algorithm to one day pick up on deadly diseases like cholera and stop an outbreak in its tracks, according to a presentation at last week’s American Physical Society’s annual Fluid Dynamics conference. Ancalle and Gatlin’s results haven’t yet been published in a peer-reviewed journal.

 

Here’s the background — Diarrheal diseases like cholera kill 500,000 children yearly, making them the third leading cause of child mortality worldwide. “There's an outbreak and resurgence in Haiti as we speak,” Gatlin says. Ramping up the detection of diseases would bolster treatment and prevent outbreaks, she explains.

 

Why it matters — The goal is to combine the machine-learning model with inexpensive sensors and deploy them in regions susceptible to outbreaks of diarrheal disease. “And as we classify those events, we can start to collect that data,” Gatlin says. “It can say, ‘Hey we're seeing an outbreak of lots of diarrhea.’ Then we can start to quickly diagnose what's going on in an area.’”

 

What they did — Until recently, Ancalle wasn’t thinking much about diarrhea. “Our initial focus for that first year was really on flatulence and urination,” he says. He and his colleagues were trying to relate the sound of farts to the internal geometry of a rectum — abnormal changes could mean cancer. “After discussing with gastroenterologists we thought that it would be a good way to try for a non-invasive route.”

 

But the project soon expanded: Ancalle teamed up with researchers at GTRI who were figuring out ways to passively detect outbreaks of gastrointestinal diseases. Perhaps, they wondered, next-gen toilets could do more than collect excrement — they could also help alert communities of an outbreak.

 

That’s where acoustics come in. Sound is easier to analyze remotely than video or self-reporting, and it’s less invasive or cumbersome than a medical examination. And the sounds of our outputs — urination, flatulence, solid defecation, and diarrhea — are distinct. The team realized that an inexpensive device and an AI algorithm could organize this toilet information.

 

They began by sorting through publicly available audio and video of excretions, capturing the frequency spectrum from each, and feeding it to a machine-learning algorithm. Their AI then learned from all that doodoo data until it was primed for S.H.A.R.T. machine testing.

 

The S.H.A.R.T. machine is a couple of feet wide and has loads of nozzles and attachments. The team pumps water through the machine and records the sounds. They learned the physics behind the sound of each excretion and designed the device to simulate those same dynamics — tinkering with different attachments for each subsystem. “A lot of thought went into each of the sounds,” Gatlin says. “There was a subsystem for each sound on this little machine.”

 

“It actually performs pretty well,” she continues. Their algorithm identified the correct “excretion event” up to 98 percent of the time, according to early data.

 

The team is also exploring the fundamental physics at play. In the conference presentation, Ancalle described how the team modeled the sound of male urination (streams turning into droplets that splash in succession.)

 

If the geometry of the urethra changes, so do the stream and the sound. Now, Ancalle is working with urologists to use the same machine-learning approach to detect irregular changes in urination and flatulence based on this idea.

 

“Self-reporting is not very reliable,” Ancalle says. “We're trying to find a non-invasive way where people can get a notification on whether or not they should go get checked out. Like ‘Hey, your urine is not flowing at the rate that it should. Your farts are not sounding the way they should. You should check it out.’” They propose that changes in the tract — from cancer or another condition — would manifest in these acoustics.

 

“It’s reasonable to assume that you can detect it with microphones,” says Jared Barber, an applied mathematician from Indiana University who chaired the session but isn’t involved in the research. Ancalle has also worked on a female urination model but had only completed the male model in time for his presentation.

 

What’s next — The researchers are looking to expand their testing and eventually build a deployable device, which could include a tiny Raspberry Pi computer. Gatlin envisions pairing this project with ongoing sustainable toilet projects.

 

Barber notes that the work is very preliminary, but he was encouraged by the talk. “It seems like it could have a very large impact,” Barber says. “It all seems feasible. They are using techniques that can deliver the hopeful capability for diagnosis.”

 

It’s still early days, but the team is designing with the end product in mind. “We're not trying to come up with million-dollar equipment,” Ancalle says. “We are trying to make this something that can be afforded by just everyone, particularly since the project is focused on urban areas with weak health systems. The affordability aspect is very important for us.”

Cultured colon cancer cells showing the nuclei stained with DAPI in blue, the actin cytoskeleton in red and plectin (isoform 1k) in green. Plectin interacts with cytoskeletal actin, affecting its behaviour. This subtype of plectin promotes the migration of cells and may affect metastasis.

 

Gastrointestinal issues are not uncommon and when treated at the right time they can be completely cured. Some of these problems include colon cancer, GERD, irritable bowel syndrome, inflammatory bowel disease and diseases related to the pancreas and liver. If you are a resident of Miami Lakes, Greater Miami, South Broward and Hialeah areas, visit Digestive Medical Associates for proper screening and treatment of the diseases. Highly certified and skilled professionals are attached to the clinic. For more information, browse through digestivemed.com/.

 

Tuesday tea. Today is all about white food. Steamed ling with coconut rice.

#YummyLummy #FoodPhotography #NotLowCarb #WhiteFood #MasterChefAU #BowelPrep

Ling, Rice, Coconut cream, Vegetable stock

 

G'day food lovers,

 

I'm having a colonoscopy on Thursday and I've started the bowel preparation by drinking lots of water and eating white food. I ate eggs for breakfast and bread rolls for smoko, lunch, and arvo tea. Tomorrow I start the laxatives to flush out my bowels and clean the mucosa so the gastroenterologist can have a good gander and not miss anything important like a malignant tumour. So for tea, I cooked some rice and put it into a frypan with a little vegetable stock. Once the liquid was bubbling I tossed in some ling cubes and put the lid on for five minutes to ensure the big thick pieces of ling were cooked. I then added in half a tin of coconut cream and let that simmer for five minutes before serving and eating.

It wasn't too bad. Have a good night. Catch you later.

Robynne Chutkan

CEO, Gutbliss LLC; Integrative Gastroenterologist

 

Mark Hyman

Head of Strategy and Innovation, Cleveland Clinic Center for Functional Medicine

 

Facilities at KKasturi Hospital in Bhayandar

 

High end ASPEN Sonography machine of ACUSON make for whole body colour doppler, carotid and renal doppler, 2D Echocardiography with colour doppler and whole body sonography. Portable sonography & 2D Echocardiography facility is also available.

 

Portable USG & 2 D ECHO Facility available at Home also.

 

About KKasturi Hospital

---------------------------------

KKASTURI MEDICARE PVT. LTD. located at Mira Bhayandar has 60 bedded indoor facility with Polyclinic, Diagnostic Centre, ICCU, NICU, Dialysis Unit, Pediatric, Surgical, Maternity & General Hospital that meets the standards of “One Stop Hi - Tech Centre. ” We believe in Health Care.... Human Care"

 

We also offer Medical Tourism for our International Patients

 

For more detail about KKasturi Hospital in Mira Bhayander Visit www.kasturihospital.com

 

DOCTOR LUIS CARLOS SABBAGH specialised throughout inner drugs is usually noticed in professional medical studies at Javeriana University or college throughout Bogotá. His specialty in Gastroenterology and The disgestive system Endoscopy together with Ultrasound graduates Proctology intestinal health and fitness ended up being carried out in the College or university Associated with Venice VII – Portugal. Click here to know more about www.facebook.com/luiscarlos.sabbagh

Gastrointestinal and hepatological problems when screened and diagnosed at the right time can cure things easily. Digestive Medical Associates has board certified professionals and physicians in the team who can carry out screenings and treatments of colon cancer, irritable bowel syndrome, inflammatory bowel disease, GERD and problems related to liver and pancreas. The center has offices in three locations. To find out about the centers and services click on digestivemed.com/.

My right side had been hurting for a few days. I'd gone to a gastroenterologist who'd told me he thought it was my gallbladder. He ordered an ultrasound, an endoscopy, and about a week's worth of stool samples, which was a nightmare. I was VERY psyched when I learned that you could still drink with gallstones.

BILL ADAMS: Special to North Hawaii News.

 

Participants of a Ballroom Dancing class held at Waimea Elementary School in...you guessed it...Waimea, which is also known as Kamuela in order to confuse people.

 

This was one of approximately 500 photos taken during this 2-hour assignment. The male is gastroenterologist Dr. Ron Ah Loy.

Facility in KKasturi Multi Specialty Hospital In Mira Bhayandar

 

Dialysis Unit

-----------------

 

Three Nipro make aulomatic dialysis machines with reverse osmosis water purification plant, trained technician & round the clock availability of nephrologist.

 

About KKasturi Hospital

---------------------------------

KKASTURI MEDICARE PVT. LTD. located at Mira Bhayandar has 60 bedded indoor facility with Polyclinic, Diagnostic Centre, ICCU, NICU, Dialysis Unit, Pediatric, Surgical, Maternity & General Hospital that meets the standards of “One Stop Hi - Tech Centre. ” We believe in Health Care.... Human Care"

 

We also offer Medical Tourism for our International Patients

 

For more detail about KKasturi Hospital in Mira Bhayander Visit www.kasturihospital.com

www.grid.news/story/science/2022/08/12/beyond-paxlovid-fo...

 

Beyond Paxlovid for covid-19: Scientists are scrambling to make better covid antiviral medications

Here’s what the next generation of drugs might look like.

 

Antiviral drugs like remdesivir, molnupiravir and Paxlovid have undoubtedly saved lives and reduced the suffering wrought by covid-19 since they began rolling out in fall of 2020.

 

But they’re far from perfect, as President Joe Biden’s recent experience shows. After treatment with Paxlovid, his covid infection rebounded, though his symptoms were mild.

 

With the pandemic showing no signs of slowing, the hunt for the next generation of covid treatments is speeding up. Pfizer and Merck — the makers of Paxlovid and molnupiravir, respectively — already have potential drug candidates that work better, or are easier to take, in their development pipelines. And many smaller biotech companies are also entering the race. They include Enanta Pharmaceuticals, which earlier this month reported a successful Phase I clinical trial of its experimental covid drug. Meanwhile, the Biden administration said in June that it planned to spend more than $3 billion to accelerate the search for better covid antiviral drugs.

 

“I think the technical word to describe [the current covid] drugs would be suboptimal,” said Luis Schang, a virologist at Cornell University. The drugs, all of which stem from antivirals developed before SARS-CoV-2 existed, have been a first good stab at beating back the virus in the body, he said, “but they all have limitations.”

 

But in the history of antiviral drugs, less-than-perfect initial stabs are the norm, experts said, drawing parallels with efforts to develop effective treatments for conditions like HIV and hepatitis C.

 

“The first drug that we used against HIV, to be quite honest, was miserable,” Schang said. AZT, first approved in 1987, caused serious side effects, and its effectiveness wore off quickly — sometimes in just days — as the virus evolved resistance. It took nearly a decade of research for scientists to develop a breakthrough triple-drug therapy in 1996 that combined several antiviral drugs to combat resistance. But the regimes involved complicated dosing and serious side effects that hampered their use. Now, there are more than 30 antiviral drugs for HIV, and it’s possible to treat the condition with just one pill a day.

 

Those first-generation drugs were better than nothing, but it took years of research to find better options. “As the second-, third- and fourth-generation drugs were developed, the drugs got more potent, had less side effects and can be given less often,” said Sara Cherry, an immunologist at the Perelman School of Medicine at the University of Pennsylvania. “It really speaks to the fact that every development of a new drug can help mitigate all the things about the first generation that were imperfect.”

 

From the earliest days of the pandemic, researchers and pharmaceutical companies have suspected that the first covid drugs to market wouldn’t end up being the final word on treating the disease.

 

When clinical trial data showed remdesivir to be the first effective coronavirus drug, Anthony Fauci, Biden’s medical adviser and leader of the National Institute of Allergy and Infectious Disease since 1984, cautioned that this was just the beginning, reflecting on his involvement in early HIV drug research. “That was not the end game, because building on that every year after we did better and better, we had better drugs of the same type, and we had drugs against different targets,” Fauci said.

 

The second-generation covid antivirals closest to approval will likely target similar aspects of the coronavirus as existing drugs, but better. Pfizer is reportedly working on an improved version of Paxlovid that would make it less problematic for people taking other medications, and the Japanese company Shionogi developed a once-a-day drug that works similarly to Paxlovid (which must be taken multiple times a day), that could be approved within months. An infusion of research money into a long-neglected field is fueling experimentation, with many labs developing new ways of stopping SARS-CoV-2, some of which might work against many other viruses.

 

“In the future, I think that we’re going to have more drugs against similar targets, we’re going to have drugs against new targets. And hopefully, we’ll have combinations in the future that will really slam the virus,” Cherry said.

 

Many ways to stop a virus

Viruses are little more than tangled strands of genetic material (RNA, in SARS-CoV-2′s case) enclosed in a protein shell. They don’t have the ability to reproduce on their own and instead hijack the machinery of their hosts to copy themselves.

 

Antiviral drugs are designed to gum up this process. “Viruses that aren’t reproducing don’t cause acute disease, typically,” said Jeffrey Glenn, a gastroenterologist and molecular virologist at Stanford University. “So, we want to interfere with their ability to reproduce themselves.”

 

Most existing antiviral drugs, for any disease, aim to disrupt something about the virus itself. Many target viral polymerases, the proteins viruses use to make copies of their genetic material once they infect a host. Remdesivir, for instance, mimics the coronavirus’ genetic material, halting replication. Another common target is viral proteases, enzymes a virus needs to make proteins that make more viruses. The active ingredient in Paxlovid, which consists of two medications, inhibits a key enzyme needed to produce this replication machinery. The other ingredient slows the body’s metabolism of the active ingredient, helping it work longer.

 

“In cell culture, these all work quite well to block viral infection,” said Cherry. “But when you move into an organism, there’s a lot more complications,” she said. Our bodies might break down a drug too quickly for it to clear enough virus, or the drug may not reach peak concentration in the lung or respiratory tract, where viral replication is happening. With potentially billions of viral particles to counter, getting this concentration right really matters, Cherry said, and can take time to perfect.

 

Imperfect single antivirals can also foster the evolution of drug-resistant strains of a virus. By knocking down susceptible strains in an infected individual, the antiviral can give resistant strains a leg up, allowing them to flourish within that individual and spread. “The single drugs initially used for HIV evolved resistance generally quickly,” said Matthew Frieman, a coronavirus researcher at the University of Maryland. “It wasn’t until they started combining two and three and four drugs together, these drug cocktails, that scientists learned this worked much more efficiently.”

 

Combining multiple antiviral drugs makes it much harder for a virus to evolve resistance, since it’s being hit from many different angles at different stages of the replication cycle, Frieman said. The strategy is often simply more effective, too. “By hitting it at multiple steps in life cycle, you can really enhance the effects of any one of these drugs individually,” he said. “You can also generally use less of each drug, which can reduce side effects.”

 

Identifying drugs that might work together is one crucial step, and scientists have already begun testing different combinations in the lab. “The other part is combining together drugs developed by different companies,” Frieman said. “It becomes an issue of money and patent rights, which can be difficult.” Altogether, the process of developing combination therapy can take many years, he said.

 

There are currently no trials underway testing Paxlovid with other drugs, and some experts worry that combining molnupiravir, which works by introducing mutations into SARS-CoV-2′s genetic material, could breed resistant strains. Consequently, more antiviral drugs may need to get developed before combination therapies come online. Thankfully, scientists are looking for new targets at an unprecedented scale in antiviral research.

 

Finding new targets

Most antiviral drugs, for any condition, target two key factors of viral replication, polymerases and proteases. “I expect the next generation [of covid antivirals] will come from optimized protease and polymerase inhibitors,” said Schang. Some versions, which are easier to take and have fewer drug interactions, might be approved within months. But many scientists are starting to think beyond these targets.

 

“Antiviral therapies are heavily biased toward protease inhibitors and polymerase inhibitors,” said Schang, “and that’s resulted in a relative scarcity of chemical scaffolds that are known to have antiviral activity. That’s a major limitation moving forward. We have to have more chemical diversity.”

 

There are many ways to throw a wrench in viral replication. For example, before a virus can replicate, its viral RNA must be unwound by enzymes called helicases.“ There are lots of programs trying to develop helicase inhibitors against SARS-CoV-2,” Cherry said. Other scientists are working on ways of creating chinks into the coronavirus’ armor, designing antivirals that blow apart the protein shell that encases viral genetic material.

 

Other researchers are trying to design drugs that deprive viruses the opportunity to usurp our cells, by latching onto parts of human cells that the virus hijacks to invade or blocking access to human cellular components the virus needs to reproduce.

 

The approach is relatively new, and few drugs use it, but so-called host-directed antivirals could have advantages, said Glenn of Stanford. “Since you’re targeting something not under the virus’ control, we predict a high barrier to development of resistance,” he said. Such drugs might work against other viruses too. “If one virus has evolved to depend on a certain host function, it’s likely others have too,” he said.

 

Finally, there’s a third class of antivirals, called immune modulators, that seek to supercharge how our bodies naturally deal with infection. Interferons are proteins that whir into action at the first sign of an infection, kick-starting the immune response. Peginterferon lambda, a drug developed by Eiger Biopharmaceuticals, has shown exciting results in an early clinical trial. One shot of the drug cut risk of hospitalization by half when administered early in vaccinated patients and by 89 percent when administered early to unvaccinated patients. Glenn, who founded Eiger and sits on its board of directors, said the company plans to request emergency use authorization from the Food and Drug Administration.

 

Efficacy and ease of use aren’t the only factors that will shape the next iterations of covid antivirals. To be maximally effective, the drugs need to relatively inexpensive and easy to manufacture and distribute worldwide, Cherry said. “That’s actually not so trivial,” she said, but is key to ensuring the kind of equitable access that represents the world’s best bet toward controlling the pandemic.

 

But with unprecedented funding and interest in antivirals, many researchers are optimistic. Not only might the next generations of SARS-CoV-2 antivirals transform the nature of the pandemic, they might bolster our antiviral arsenal such that we’re better prepared for the next major infectious disease threat. “There’s no limit to the creativity and novelty of all these new targets,” Frieman said. “Which ones work and which ones won’t work, I don’t know, but I think that the future is really bright for the number of antivirals that will be developed in the next decade.”

With Melinda's prize container veggies - green, red & yellow peppers, 3 kinds of tomatoes, yellow & green beans, sitting on her deck has been "food for the soul and for the gut". The word "gut" comes from working for a gastroenterologist! 'Tongue-in-cheek', they are sometimes referred to as "Crop & Gizzard men" in the medical community!

2 4 5 6 7 ••• 47 48